VIRMA and breast cancer: However, as full-length VIRMA is the dominant isoform in breast cancers (Fig. 2B, S4C), its overexpression and impact on m6A changes is likely to be more relevant to the development and maintenance of breast cancer than N-terminal VIRMA.